Amussen Hunsaker Associates LLC Merck & Co., Inc. Transaction History

Amussen Hunsaker Associates LLC

  • $645 Million
  • Q2 2024

A detailed history of Amussen Hunsaker Associates LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Amussen Hunsaker Associates LLC holds 8,217 shares of MRK stock, worth $837,147. This represents 0.16% of its overall portfolio holdings.

Number of Shares
8,217
Previous 8,211 0.07%
Holding current value
$837,147
Previous $1.08 Million 6.09%
% of portfolio
0.16%
Previous 0.18%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$123.8 - $132.96 $742 - $797
6 Added 0.07%
8,217 $1.02 Million
Q1 2024

May 15, 2024
SELL
$113.24 - $131.95 $20,043 - $23,355
-177 Reduced 2.11%
8,211 $1.08 Million
Q4 2023

Feb 13, 2024
BUY
$100.18 - $109.02 $18,833 - $20,495
188 Added 2.29%
8,388 $914,000
Q3 2023

Nov 13, 2023
SELL
$102.95 - $114.33 $6,177 - $6,859
-60 Reduced 0.73%
8,200 $844,000
Q2 2023

Aug 09, 2023
BUY
$108.61 - $118.38 $868 - $947
8 Added 0.1%
8,260 $953,000
Q1 2023

May 15, 2023
BUY
$102.94 - $114.86 $63,616 - $70,983
618 Added 8.1%
8,252 $877,000
Q4 2022

Feb 07, 2023
BUY
$87.44 - $112.11 $786 - $1,008
9 Added 0.12%
7,634 $846,000
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $4,226 - $4,748
-50 Reduced 0.65%
7,625 $657,000
Q2 2022

Aug 15, 2022
BUY
$83.49 - $94.64 $751 - $851
9 Added 0.12%
7,675 $700,000
Q1 2022

May 11, 2022
SELL
$73.51 - $82.4 $26,831 - $30,076
-365 Reduced 4.54%
7,666 $628,000
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $15,251 - $19,103
211 Added 2.7%
8,031 $618,000
Q3 2021

Nov 16, 2021
BUY
$71.68 - $78.83 $2,723 - $2,995
38 Added 0.49%
7,820 $587,000
Q2 2021

Aug 17, 2021
SELL
$70.31 - $77.77 $70 - $77
-1 Reduced 0.01%
7,782 $612,000
Q1 2021

May 18, 2021
SELL
$68.86 - $81.11 $1,996 - $2,352
-29 Reduced 0.37%
7,783 $599,000
Q4 2020

Feb 17, 2021
BUY
$71.77 - $79.65 $645 - $716
9 Added 0.12%
7,812 $639,000
Q3 2020

Nov 16, 2020
BUY
$73.18 - $82.95 $62,056 - $70,341
848 Added 12.19%
7,803 $609,000
Q2 2020

Aug 17, 2020
SELL
$70.42 - $80.13 $51,899 - $59,055
-737 Reduced 9.58%
6,955 $602,000
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $22,746 - $31,527
-359 Reduced 4.46%
7,692 $564,000
Q4 2019

Feb 14, 2020
BUY
$77.58 - $87.54 $59,115 - $66,705
762 Added 10.45%
8,051 $733,000
Q2 2019

Aug 20, 2019
BUY
$69.84 - $81.59 $349 - $407
5 Added 0.07%
7,289 $611,000
Q1 2019

May 16, 2019
BUY
$69.58 - $79.36 $89,340 - $101,898
1,284 Added 21.4%
7,284 $606,000
Q4 2018

Feb 19, 2019
SELL
$65.24 - $75.71 $67,131 - $77,905
-1,029 Reduced 14.64%
6,000 $458,000
Q3 2018

Nov 16, 2018
BUY
$57.69 - $67.84 $405,503 - $476,847
7,029 New
7,029 $499,000

Others Institutions Holding MRK

# of Institutions
3,808
Shares Held
1.92B
Call Options Held
13.4M
Put Options Held
10.6M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email